Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxanthine phosphoribosyltransferase 1 pseudogene 2 (HPRT1P2) is an intronless processed pseudogene found on human chromosome 5 that shares high sequence similarity with the functional HPRT1 gene, but lacks the capacity to produce a functional protein[2][4][1]. Pseudogenes are nonfunctional segments of DNA resembling protein-coding genes, often arising by gene duplication or retrotransposition. They typically lack regulatory sequences and accumulate disabling mutations such as frameshifts or premature stop codons[4]. While some pseudogenes have regulatory roles at the RNA level, no specific biological or disease functions are attributed to HPRT1P2, nor does it interact with drugs or serve as a therapeutic target[4][2][1].
None (not a drug target; mechanisms are not applicable)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxanthine phosphoribosyltransferase 1 pseudogene 2 (HPRT1P2).